Cost-utility analysis compares cationic emulsion latanoprost with non-emulsion latanoprost in patients, suggesting potential benefits for those with ocular surface disease.
Background This study evaluated the efficiency CE-latanoprost unidose (cationic emulsion of latanoprost) versus latanoprost unidose (non-emulsion formulation) in open-angle glaucoma and ocular hypertension (OAG/OHT) with concomitant ocular surface disease (OSD) patients' treatment in Spain.
No takes yet. Share an insight, caveat, or question.
Canut et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: